2008 - Bivalirudin reduced major bleeding and adverse events in patients with STEMI having PCI
- Conservative Anticoagulant Therapy of Acute Myocardial Infarction. Griffith, George C.; Leak, David; Hegde, Balakrishna // Annals of Internal Medicine;Aug62 Part 1, Vol. 57 Issue 2, p254
Discusses the effectiveness of anticoagulant therapy for acute myocardial infarction using different variables. Age of the patient; Severity of the attack; Grade of anticoagulant therapy.
- Anticoagulants in Acute Myocardial Infarction: The Last (?) Word. Wasserman, Albert J. // Annals of Internal Medicine;Oct69, Vol. 71 Issue 4, p855
Editorial. Deals with the efficacy of anticoagulants in treating acute myocardial infarction. Overview of studies on anticoagulants; Criticisms on the study by the Working Party on Anticoagulant Therapy in Coronary Thrombosis.
- Bleeding risk post-MI increased with number of antithrombotic drugs. // Hem/Onc Today;1/25/2010, Vol. 11 Issue 2, p23
The article focuses on a study which found that the risk for hospitalization due to bleeding in patients who have had a myocardial infarction increased with the increasing number of antithrombotic drugs patients were assigned.
- RATIO: Lupus anticoagulant risk factor for arterial thrombosis. // Hem/Onc Today;10/25/2009, Vol. 10 Issue 20, p9
The article discusses research on the relationship between lupus anticoagulants and increased risk for myocardial infarction and ischemic stroke in women aged younger than 50 years, conducted by R. T. Urbanus et al, published in a 2009 issue of the journal "Lancet Neurology."
- Clot-busters for `brain attacks'. E.B. // Medical Update;Mar97, Vol. 20 Issue 9, p4
Examines the use of clot-dissolving drugs in treating heart attack patients. Problems faced by physicians in treating stroke; Seeming neglect of physicians on using an aggressive approach to treating stroke.
- Benefits of post-MI anticoagulation outweigh risks, study finds. // Geriatrics;Nov93, Vol. 48 Issue 11, p26
Reports on the clinical benefit of long-term anticoagulation therapy after myocardial infarction (MI). Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis study; Reduction in risk of MI by patients who received warfarin.
- Antithrombotic drug called useful adjunct to streptokinase. // Geriatrics;May94, Vol. 49 Issue 5, p20
Reports on a medical trial using an antithrombotic agent called Hirudin in the treatment of patients with acute myocardial infarction (MI). Usefulness as an adjunct to streptokinase; Inhibition of both free and clot-bound thrombin; Trend toward lower rates of mortality and clinical events.
- Anticoagulant Therapy in the Relatively Young Male with Myocardial Infarction. Myers Jr., John E.; Bauer, Frank L. // Annals of Internal Medicine;Nov61, Vol. 55 Issue 5, p760
Investigates anticoagulant therapy for acute myocardial infarction in young male patients. Comparison of anticoagulant and non-anticoagulant therapy; Rationale for anticoagulant therapy; Mortality rates after therapy.
- Long term outcome of patients with postinfarction left ventricular pseudoaneurysm. Moreno R; Gordillo E; Zamorano J; Almeria C; Garcia-Rubira J C; Fernandez-Ortiz A; Macaya C // Heart;Oct2003, Vol. 89 Issue 10, p1144
BACKGROUND: It is debatable whether surgical repair is routinely indicated in asymptomatic patients with left ventricular pseudoaneurysms. OBJECTIVE: To evaluate the long term outcome of patients with pseudoaneurysm after myocardial infarction, focusing on those treated conservatively. METHODS:...